These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16270734)

  • 1. American Kidney Fund reaches out to minority communities at risk for CKD.
    Daniels FA
    Nephrol News Issues; 2005 Oct; 19(11):47-8. PubMed ID: 16270734
    [No Abstract]   [Full Text] [Related]  

  • 2. The American Kidney Fund's effort to help minorities with CKD.
    Daniels FA; Palmer S
    Nephrol News Issues; 2003 Oct; 17(11):52-3, 57. PubMed ID: 14593822
    [No Abstract]   [Full Text] [Related]  

  • 3. Results in KEEP's first report show progress in early identification of CKD patients.
    Neumann ME
    Nephrol News Issues; 2003 Nov; 17(12):84-7. PubMed ID: 14640014
    [No Abstract]   [Full Text] [Related]  

  • 4. Sifting through the kids: should children be screened for CKD?
    Partridge C
    Nephrol News Issues; 2006 Nov; 20(12):36-7. PubMed ID: 17125094
    [No Abstract]   [Full Text] [Related]  

  • 5. CKD awareness in the United States: the Kidney Early Evaluation Program (KEEP).
    Saab G; Whaley-Connell AT; McCullough PA; Bakris GL
    Am J Kidney Dis; 2008 Aug; 52(2):382-3. PubMed ID: 18640489
    [No Abstract]   [Full Text] [Related]  

  • 6. Sustainable community-based CKD screening methods employed by the National Kidney Foundation's Kidney Early Evaluation Program (KEEP).
    McCullough PA; Brown WW; Gannon MR; Vassalotti JA; Collins AJ; Chen SC; Bakris GL; Whaley-Connell AT
    Am J Kidney Dis; 2011 Mar; 57(3 Suppl 2):S4-8. PubMed ID: 21338848
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening populations at increased risk of CKD: the Kidney Early Evaluation Program (KEEP) and the public health problem.
    Vassalotti JA; Li S; Chen SC; Collins AJ
    Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S107-14. PubMed ID: 19231754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes mellitus and CKD awareness: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES).
    Whaley-Connell A; Sowers JR; McCullough PA; Roberts T; McFarlane SI; Chen SC; Li S; Wang C; Collins AJ; Bakris GL;
    Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S11-21. PubMed ID: 19285607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SCreening for Occult REnal Disease (SCORED): a simple prediction model for chronic kidney disease.
    Bang H; Vupputuri S; Shoham DA; Klemmer PJ; Falk RJ; Mazumdar M; Gipson D; Colindres RE; Kshirsagar AV
    Arch Intern Med; 2007 Feb; 167(4):374-81. PubMed ID: 17325299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Executive summary: Kidney Early Evaluation Program (KEEP) 2008 annual data report.
    Bakris GL; McCullough PA; Collins AJ
    Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S1-2. PubMed ID: 19285606
    [No Abstract]   [Full Text] [Related]  

  • 11. Minorities and ESRD. Part II. Tracking causes of ESRD in the Hispanic population.
    Pugh J
    Nephrol News Issues; 1995 Oct; 9(10):13, 16. PubMed ID: 7494589
    [No Abstract]   [Full Text] [Related]  

  • 12. Minorities and ESRD. Part I. Tracking the causes of ESRD in the Hispanic population.
    Pugh J
    Nephrol News Issues; 1995 Sep; 9(9):34. PubMed ID: 7501034
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypertension in early-stage kidney disease: an update from the Kidney Early Evaluation Program (KEEP).
    Kalaitzidis R; Li S; Wang C; Chen SC; McCullough PA; Bakris GL
    Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S22-31. PubMed ID: 19285608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CKD in the United States: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004.
    Whaley-Connell AT; Sowers JR; Stevens LA; McFarlane SI; Shlipak MG; Norris KC; Chen SC; Qiu Y; Wang C; Li S; Vassalotti JA; Collins AJ;
    Am J Kidney Dis; 2008 Apr; 51(4 Suppl 2):S13-20. PubMed ID: 18359403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).
    Bhuriya R; Li S; Chen SC; McCullough PA; Bakris GL
    Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S3-10. PubMed ID: 19285609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for proteinuria and chronic kidney disease risk factors in Kinshasa: a World Kidney Day 2007 study.
    Sumaili EK; Nseka NM; Lepira FB; Krzesinski JM; Makulo JR; Bukabau JB; Nkoy JB; Mokoli VM; Longokolo MM; Owandjalola JA; Kayembe PK
    Nephron Clin Pract; 2008; 110(4):c220-8. PubMed ID: 18974653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uremic syndrome and end-stage renal disease: physical manifestations and beyond.
    Chikotas N; Gunderman A; Oman T
    J Am Acad Nurse Pract; 2006 May; 18(5):195-202. PubMed ID: 16681706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health disparities in chronic kidney disease: are we making any progress?
    Young BA; Hall Y; Rodriguez RA
    Nephrol News Issues; 2009 Apr; 23(4):48, 50-1. PubMed ID: 19437948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting development of CKD in the general population--early days in a rapidly evolving field.
    Pauly RP; Tonelli M
    Am J Kidney Dis; 2011 Jun; 57(6):805-7. PubMed ID: 21601124
    [No Abstract]   [Full Text] [Related]  

  • 20. Reducing the burden of chronic kidney disease among American Indians.
    Narva AS
    Adv Chronic Kidney Dis; 2008 Apr; 15(2):168-73. PubMed ID: 18334242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.